These medications are highly effective for weight reduction, but their strong appetite-suppressing effects can reduce protein intake
The retail pharmacies segment is furthermore predicted to hold a significant share of the market during the projected period
Helsinn Group (formerly Zealand Pharma) advanced ipamorelin through clinical development before discontinuation
Before starting semaglutide treatment, during the consultation, we will discuss your medical history and any concerns you might have about the procedure to ensure that the benefits of the medication outweigh any potential risks
Starting elderly patients at 2.5 mg remains appropriate, but extending each dose tier to 6 to 8 weeks rather than 4 weeks improves tolerability
This one is more nuanced, but the short answer is yes, people with significant kidney or liver disease should be very cautious and likely avoid it